ICF helps FDA accelerate the drug labeling review process with AWS machine learning
AWS Public Sector
MAY 30, 2024
Within the Food and Drug Administration’s Center for Drug Evaluation and Research, the Division of Medication Error Prevention and Analysis (DMEPA) plays a critical role. DMEPA reviews premarket and postmarket drug labeling to minimize the risk of medication errors. In partnership with FDA’s DMEPA team, Amazon Web Services (AWS) Partner ICF is developing a machine learning (ML) prototype known as the Computerized Labeling Assessment Tool (CLAT).
Let's personalize your content